1/4 Just publ in the Lancet our updated network meta-analysis of imaging-guided (OCT or IVUS) vs. angio-guided PCI across the spectrum of CAD. With 22 RCTs and 15,964 pts this is the 1st study to demonstrate that imaging reduces all-cause death (by 25%), as well as all MI (17%).

I’m all for more evidence surrounding benefit of IVI : “enhances both the safety and effectiveness of PCI, reducing the risks of death, myocardial infarction, repeat revascularisation, and stent thrombosis.” #CardioTwitter SCAI Women in Innovations American College of Cardiology

Q: What is the performance of coronary IVL in calcified coronary lesions in a real-life, all-comers, setting? A: Immediate and 30-day outcomes were excellent, with a very low rate of MACE despite the high-risk nature of the patient population. bit.ly/3ORJsJG #JACCINT

This is how administrators view us. We are no more than petulant children who must be hounded to do the "important" work of documentation. It doesn't matter if you've been doing emergency cases, up all night, and exhausted. It doesn't matter if you just want to spend some time

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

Goodbye, old friend?? Beta-blocker therapy did not reduce death and MI in AMI with preserved LVEF at one year. nej.md/4akVhRx American College of Cardiology #ACC24

DanGer Shock: Routine implantation of Impella CP on top of standard care is superior to standard care alone in reducing 6-month mortality among patients presenting w/ #STEMI & cardiogenic shock, despite a higher risk of complications. 🔗 bit.ly/3VOcLRG #ACC24

The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years. Read more: bit.ly/3xuHWrl #ACC24

Made it to my connecting flight… barely😅 #SCAI2024 here I come! Looking forward to making new connections, and catching up with friends and mentors!

Been having a theme with several ostial RCA cases lately… so tedious to ensure you cover the os but don’t have too much tension in the system that everything flies out! 😅

Everything about calcified nodules! authors.elsevier.com/a/1j9qM6uPJvuU… JACC Journals Doosup Shin jcspratt Akiko Maehara Carlos Collet MD PhD Emanuele Barbato Flavio Ribichini Nieves Gonzalo @koshiro__Sakai Gregg W. Stone MD Evan Shlofmitz @drallenj OPCI St. Francis Hospital & Heart Center Cardiovascular Research Foundation David J. Cohen, MD, MSc Fernando A Sosa

🎉The wait is finally over! As of today, #InterventionalCardiology fellowship applicants can submit applications for the July 2025 cycle. Programs will start reviewing these applications on July 17. Learn more ➡️ scai.org/membership/car… #CardioTwitter #SCAIFellowshipMatch #Match

Thank you shockwave for your service! 😜 #ivusguided #CardioTwitter #wic Shockwave Medical SCAI

Me, when someone is telling me why they don’t use intra-coronary imaging…

🆕 The "2024 AHA/ACC/Multisociety Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations for perioperative cardiovascular evaluation & management of adult patients undergoing noncardiac surgery. Read the guideline in #JACC:

Read the new Expert Consensus Update on the Management of Patients with #STEMI Referred for Primary #PCI in MyJSCAI highlighting strengths and limitations of various diagnostic and therapeutic interventions for STEMI treatments. Learn more ➡️ doi.org/10.1016/j.jsca…

Anyone interested in IC who is looking for a spot, jump on this! It’s a great program, high volume, and excellent faculty #CardioTwitter #scai #WIC

NEW! 2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Intravascular imaging guidance with OCT or IVUS during PCI in ACS is now recommended for left main or complex lesions with a class IA recommendation.